Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Clinical Trials Insight: 700033169

Trial Profile

Clinical Trials Insight: 700033169

Phase of Trial: Phase I

Latest Information Update: 30 May 2009

At a glance

  • Drugs ADX-10059 (Primary)
  • Indications Anxiety; Gastro-oesophageal reflux; Migraine
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
  • Sponsors Addex Therapeutics
  • Most Recent Events

    • 30 May 2009 Results for part 2 have been presented at Digestive Disease Week 2009.
    • 10 Sep 2008 Status changed from recruiting to completed.
    • 10 Sep 2008 Results reported by Addex Pharmaceuticals
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top